CollPlant Biotechnologies (CLGN) Change in Cash (2018 - 2026)

CollPlant Biotechnologies has reported Change in Cash for 9 years, with the latest figure at -$1.3 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Cash fell 13.2% year-over-year to -$1.3 million; the trailing twelve-month figure through Mar 2026 stood at -$6.5 million (up 48.17% YoY), and the FY2025 full-year result was -$6.3 million, up 57.21% from the prior year.
• Change in Cash for Q1 2026 stood at -$1.3 million, up from -$3.0 million in the prior quarter.
• The five-year high for Change in Cash was $28.1 million in Q1 2022, with the low at -$5.0 million in Q2 2022.
• Historically, Change in Cash has averaged $696705.9 across 5 years, with a median of -$2.8 million in 2023.
• Annual changes were most pronounced in 2023 — Change in Cash soared 337.95% — and 2024, when it plunged 153.65%.
• CollPlant Biotechnologies' Change in Cash stood at $17.1 million in 2022, then slumped by 114.73% to -$2.5 million in 2023, then tumbled by 37.49% to -$3.5 million in 2024, then rose by 14.62% to -$3.0 million in 2025, then surged by 55.04% to -$1.3 million in 2026.
• The last three Change in Cash figures came in at -$1.3 million (Q1 2026), -$3.0 million (Q4 2025), and -$2.9 million (Q3 2025), per Business Quant data.